Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Directly Reprogramming Nerve Cells in the Brain

By LabMedica International staff writers
Posted on 04 Apr 2013
Generating new cells in the body to cure disease, the purview of cell therapy, has taken another significant step in the development toward new treatments. More...
New Swedish research demonstrated that it is possible to reprogram other cells to become nerve cells, directly in the brain.

Two years ago, researchers in Lund University (Sweden) were the first in the world to reprogram fibroblasts to dopamine-producing nerve cells, without going through the stem cell stage. The scientists are now going further and shown that it is possible to reprogram both skin cells and support cells directly to nerve cells, in place in the brain.

“The findings are the first important evidence that it is possible to reprogram other cells to become nerve cells inside the brain,” said Dr. Malin Parmar, research group leader and reader in neurobiology at Lund.

The researchers employed genes designed to be switched on or off using a drug. The genes were inserted into two types of human cells, glia cells and fibroblasts, support cells that are naturally present in the brain. Once the researchers had transplanted the cells into the brains of rats, the genes were triggered using a drug in the animals’ drinking water. The cells then began their conversion into nerve cells.

In other research with lab mice, where similar genes were injected into the mice’s brains, the investigators also were able to reprogram the mice’s own glia cells to become nerve cells. “The research findings have the potential to open the way for alternatives to cell transplants in the future, which would remove previous obstacles to research, such as the difficulty of getting the brain to accept foreign cells, and the risk of tumor development,” said Dr. Parmar.

The new technique of direct reprogramming in the brain could create new ways to more successfully replace dying brain cells in disorders such as Parkinson’s disease. “We are now developing the technique so that it can be used to create new nerve cells that replace the function of damaged cells. Being able to carry out the reprogramming in vivo makes it possible to imagine a future in which we form new cells directly in the human brain, without taking a detour via cell cultures and transplants,” concluded Dr. Parmar.

The study’s findings were published March 26, 2012, in the journal Proceedings of the National Academy of Science of the United States of America (PNAS).

Related Links:

Lund University



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.